Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-06-12

FDA Approved: STRENSIQ — Supplemental Application (Alexion Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for STRENSIQ (ASFOTASE ALFA) from Alexion Pharmaceuticals, Inc. This action pertains to labeling changes under the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRENSIQ (asfotase alfa)

Snippet

SUPPL AP for STRENSIQ (ASFOTASE ALFA)